Page 4 - Optimal Management of Urologic Oncology During COVID-19
P. 4

Learning Objectives









                By the end of this program, participants will:








                • Review the healthcare disruption for uro-oncology patients

                   in this pandemic




                • Discuss surgical considerations and contingencies for

                   urologic cancers



                • Understand the prioritization of systemic therapies for


                   urologic cancers
   1   2   3   4   5   6   7   8   9